Comprehensive Cancer Centers of Nevada CCC of Nevada (1)

Las Vegas, Nevada 89109

0 studies enrolling now · 4 studies all time

What they study most

CML, Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels, Hematologic Malignancies, Metastatic Renal Cell Carcinoma, Philadelphia Chromosome Positive (Ph+), Solid Tumor, Tumors With Aberrations in ALK or ROS1

Studies at this site

• Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations — Stopped early
• Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) — Stopped early
• LGX818 for Patients With BRAFV600 Mutated Tumors — Stopped early
• Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma — Completed